A team of researchers from APL and the Johns Hopkins Bloomberg School of Public Health is developing next-generation brain organoid platforms to better understand the effects of mild blast-induced ...

J.P. Morgan announces no stabilisation for Bausch + Lomb notes Company News Published 06/19/2025, 05:04 AM 0 ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to ...

Bausch + Lomb Corp. priced a $2.33 billion leveraged loan and a €675 million ($775 million) floating-rate note as part of a $2.9 billion debt refinancing. The eye-health company tapped the junk debt ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its ...

Bausch + Lomb reported its financial results for Q1 2025 on April 30, 2025. The Company reported an adjusted net loss of $54 million for the period, as opposed to net income of $24 million in the ...

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately ...

Bausch+ Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+ Lomb Netherlands B.V. and Bausch ...

Bausch + Lomb has launched its Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops in the US. 1 Both drops will be available in most national retailers, including Walmart, Target ...